ResMed (RMD)

R&D Expenses

$105.73M

Quarterly · Period ending: · USD

RMD logo

RMD R&D Expenses

Latest reported$105.73M
RMD Quarterly R&D Expenses ($0.00 → $105.73M)
High-resolution chart · PNG

RMD r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
105,725,000
94,267,000
90,969,000
87,323,000
86,443,000
83,944,000
81,373,000
79,524,000
80,861,000
77,074,000
73,880,000
75,710,000
78,144,000
76,436,000
69,874,000
63,188,000
64,318,000
66,801,000
62,507,000
59,950,000
59,875,000
55,941,000
54,935,000
54,533,000
52,520,000
51,449,000
49,943,000
48,033,000
51,138,000
47,610,000
43,111,000
38,791,000
39,657,000
37,434,000
40,643,000
37,415,000
36,706,000
35,130,000
38,190,000
34,446,000
34,380,000
28,109,000
28,970,000
27,192,000
28,523,000
27,024,000
29,294,000
30,024,000
31,796,000
29,530,000
29,537,000
27,363,000
31,390,000
31,189,000
30,326,000
27,220,000
27,911,000
28,398,000
27,218,000
26,206,000
26,976,000
23,320,000
21,972,000
19,739,000
19,950,000
18,279,000
19,059,000
17,914,000
16,967,000
13,882,000
14,915,000
17,293,000
17,589,000
15,003,000
14,919,000
13,013,000
14,164,000
13,059,000
12,028,000
10,855,000
11,061,000
9,143,000
8,588,000
8,425,000
8,113,000
7,240,000
8,342,000
6,819,000
6,028,000
6,858,000
7,266,000
6,017,000
6,235,000
5,068,000
4,836,000
4,395,000
4,140,000
3,792,000
3,617,000
3,361,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.